(19)
(11) EP 3 143 162 A1

(12)

(43) Date of publication:
22.03.2017 Bulletin 2017/12

(21) Application number: 15792258.4

(22) Date of filing: 13.05.2015
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
(86) International application number:
PCT/US2015/030564
(87) International publication number:
WO 2015/175660 (19.11.2015 Gazette 2015/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 13.05.2014 US 201461992756 P
13.05.2014 US 201461992531 P
28.10.2014 US 201462069353 P
27.03.2015 US 201562139066 P

(71) Applicant: Rosetta Genomics Ltd.
76706 Rehovot (IL)

(72) Inventors:
  • BARNETT-ITZHAKI, Zohar
    47235 Ramat-Hasharon (IL)
  • LITHWICK YANAI, Gila
    7176677 Modiin (IL)
  • MEIRI, Eti
    6081346 Shoham (IL)
  • SPECTOR, Yael
    6522011 Tel Aviv (IL)
  • BENJAMIN, Hila
    7646414 Rehovot (IL)

(74) Representative: Pearl Cohen Zedek Latzer Baratz UK LLP 
16 Upper Woburn Place
London WC1H 0BS
London WC1H 0BS (GB)

   


(54) MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS